Company Search:
Advanced Search
Sponsored Links
Scynexis Inc Company Snapshot
Scynexis Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Scynexis Inc with three other companies in this sector in the United States: Nutriband Inc (2018 sales of $245,285.00 of which 80% was Services), Sunesis Pharmaceuticals, Inc. ($237,000.00 of which 100% was Small Molecule Therapeutics), and Cellular Biomedicine Group Inc ($224,403.00 of which 100% was Biomedicine).

Sales Analysis. During the year ended December of 2018, sales at Scynexis Inc were $257,000.00 . This is a very small increase of 0.0% versus 2017, when the company's sales were $257,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Scynexis Inc
  Stock Performance Chart for Scynexis Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 1.17
(Figures in U.S. Dollars)
1 Week -5.6%   13 Weeks 12.5%  
4 Weeks 17.0%   52 Weeks 23.2%  
Scynexis Inc Key Data:
  Ticker: SCYX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 257,000
(Year Ending Jan 2019).
Employees: 87
  Currency: U.S. Dollars Market Cap: 65,178,609
  Fiscal Yr Ends: December Shares Outstanding: 55,708,213
  Share Type: Ordinary Closely Held Shares: 2,609,202
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.